PEDRO ANTONIO RECHE GALLARDO-rekin lankidetzan egindako argitalpenak (9)

2023

  1. Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus

    Frontiers in Immunology, Vol. 14

  2. Corrigendum: Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus (Front. Immunol., (2023), 14, (1235053), 10.3389/fimmu.2023.1235053)

    Frontiers in Immunology

  3. EPIPOX: A Resource Facilitating Epitope-Vaccine Design Against Human Pathogenic Orthopoxviruses

    Methods in molecular biology (Clifton, N.J.), Vol. 2673, pp. 175-185

  4. Enhancing Regulatory T Cells to Treat Inflammatory and Autoimmune Diseases

    International Journal of Molecular Sciences, Vol. 24, Núm. 9

  5. Prediction of TAP Transport of Peptides with Variable Length Using TAPREG

    Methods in molecular biology (Clifton, N.J.), Vol. 2673, pp. 227-235

2022

  1. Resilience of Spike-Specific Immunity Induced by COVID-19 Vaccines against SARS-CoV-2 Variants

    Biomedicines, Vol. 10, Núm. 5

2021

  1. Bceps: A web server to predict linear b cell epitopes with enhanced immunogenicity and cross-reactivity

    Cells, Vol. 10, Núm. 10

  2. Human Oral Epithelial Cells Suppress T Cell Function via Prostaglandin E2 Secretion

    Frontiers in Immunology, Vol. 12

  3. Immune tolerance in the oral mucosa

    International Journal of Molecular Sciences, Vol. 22, Núm. 22